Who is sponsoring NCT05473858?

NCT05473858 is sponsored by sara nabil.

What drugs are being tested in NCT05473858?

Interventions in NCT05473858: OraVerse Injectable Product, diode laser, Anaesthesia only.

What condition does NCT05473858 study?

NCT05473858 studies Reversal of Local Anesthesia in Children.

Is NCT05473858 still recruiting?

NCT05473858 is currently recruiting now. Last updated 6 April 2026.

Last reviewed 2026-04-06 · How we verify

NCT05473858: RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oraverse Versus Laser

Recruiting now Phase 3 Last updated 6 April 2026

What this trial tests

Phase 3 trial testing OraVerse Injectable Product in Reversal of Local Anesthesia in Children in 36 participants. Currently enrolling.

Timeline

10 December 2021

Primary endpoint
10 April 2026

10 April 2026

Quick facts

Lead sponsor	sara nabil
Phase	Phase 3
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	36
Start date	10 December 2021
Primary completion	10 April 2026
Estimated completion	10 April 2026
Sites	1 location across Egypt

Drugs / interventions tested

OraVerse Injectable Product — full drug profile →
diode laser
Anaesthesia only

Conditions studied

Reversal of Local Anesthesia in Children — all drugs for Reversal of Local Anesthesia in Children →

Sponsor

sara nabil — full company profile →

Who can join

Adults 6 to 10, any sex, with Reversal of Local Anesthesia in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

clinically assess the reversal of articaine 4% of two different concentration of vasoconcentration soft-tissue local anesthesia in pediatric dentistry using Diode Laser and Oraverse

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05473858 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by sara nabil
Last refreshed: 6 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05473858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing